Five Things Must Know for Dawnzera (Donidalorsen)!

Dawnzera (Donidalorsen) is redefining the future of hereditary angioedema (HAE) prevention—it’s the first FDA-approved RNA-targeted therapy designed to reduce HAE attacks in adults and adolescents 12 years and older. With a simple autoinjector given every 4 to 8 weeks, Dawnzera offers long-lasting protection and a brand-new way to control HAE—by acting at the genetic level, not just preventing swelling.

In this video, Dr. Lin, a board-certified allergist and immunologist, breaks down the five essential things to know about Dawnzera: its indication, how it works, dosing and administration, key results from the pivotal study, and side effects and safety.

💡 Curious how Dawnzera differs from traditional preventive or on-demand HAE treatments? This episode explains it all—clearly, concisely, and backed by science.

📌 Watch Now & Learn the Truth About Dawnzera!

📢 Subscribe for more science-based medical insights, and turn on notifications so you never miss an update!

💬 Do you or someone you know live with hereditary angioedema? Share your thoughts or experiences in the comments—we’d love to hear from you!

🔗 Related Videos & Resources:
💡 Three Secrets Need to Know about Dawnzera (Donidalorsen)!
👉 Coming up.

💡 Five Things Must Know for Andembry (Garadacimab)!
👉    • Five Things Must Know for Andembry (Garada...  

💡 Five Things Must Know for Ekterly (Sebetralstat)!
👉    • Five Things Must Know for Ekterly (Sebetra...  

#Dawnzera #Donidalorsen #HereditaryAngioedema #HAE #HAETreatment #HAEPrevention #AntisenseRNA #ASOTherapy #RNAInnovation #FDAApproved #Ionis #Medician #DoctorExplains #AllergyAndImmunology #MedicianChannel #MedicalBreakthrough #PatientEducation #MedicianAllergy #HAECare #GeneticMedicine